AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.21B |
| 2 |
Advanced Micro Devices
AMD
|
+$1.15B |
| 3 |
Quanta Services
PWR
|
+$691M |
| 4 |
Trane Technologies
TT
|
+$684M |
| 5 |
RTX Corp
RTX
|
+$655M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.74B |
| 2 |
Microsoft
MSFT
|
+$2.35B |
| 3 |
Broadcom
AVGO
|
+$744M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$636M |
| 5 |
TSMC
TSM
|
+$590M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.92% |
| 2 | Miscellaneous | 10.92% |
| 3 | Healthcare | 10.85% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
Tectonic Therapeutic
TECX
$412M
| $231K | ﹤0.01% |
+7,460
| New | +$219K |
2026 Q2
0 quarters
|
|
3102
Braemar Hotels & Resorts
BHR
$98.2M
| $229K | ﹤0.01% |
96,950
+13,400
| +16% | +$32.1K |
2022 Q3
15 quarters
|
|
3103
Mistras Group
MG
$682M
| $229K | ﹤0.01% |
15,480
+3,600
| +30% | +$64.1K |
2025 Q2
4 quarters
|
|
3104
Atrium Therapeutics
RNA
$140M
| $229K | ﹤0.01% |
17,110
+4,140
| +32% | +$54.1K |
2026 Q1
1 quarter
|
|
3105
Lithium Americas
LAC
$762M
| $227K | ﹤0.01% |
57,542
+44,460
| +340% | +$212K |
2025 Q4
2 quarters
|
|
3106
Intercorp Financial Services
IFS
$5.7B
| $227K | ﹤0.01% |
+3,981
| New | +$197K |
2026 Q2
0 quarters
|
|
3107
Telos
TLS
$342M
| $225K | ﹤0.01% |
53,770
+10,491
| +24% | +$46.4K |
2024 Q2
8 quarters
|
|
3108
Repay Holdings
RPAY
$359M
| $225K | ﹤0.01% |
86,400
+11,000
| +15% | +$38.2K |
2020 Q2
24 quarters
|
|
3109
iShares Global Comm Services ETF
IXP
$573M
| $222K | ﹤0.01% |
1,932
| – | – |
2025 Q2
4 quarters
|
|
3110
CVRx
CVRX
$36.5M
| $221K | ﹤0.01% |
23,360
+5,800
| +33% | +$37.4K |
2024 Q2
8 quarters
|
|
3111
Starling Oncology
STLN
$704M
| $219K | ﹤0.01% |
71,400
+9,800
| +16% | +$41.2K |
2025 Q2
4 quarters
|
|
3112
CS Disco
LAW
$320M
| $218K | ﹤0.01% |
57,040
| – | – |
2022 Q2
16 quarters
|
|
3113
Collective Mining Ltd
CNL
$975M
| $217K | ﹤0.01% |
12,340
| – | – |
2026 Q1
1 quarter
|
|
3114
SES AI
SES
$270M
| $217K | ﹤0.01% |
+225,800
| New | +$246K |
2026 Q2
0 quarters
|
|
3115
Climb Bio
CLYM
$605M
| $217K | ﹤0.01% |
+31,670
| New | +$327K |
2026 Q2
0 quarters
|
|
3116
VNET Group
VNET
$1.08B
| $215K | ﹤0.01% |
25,665
| – | – |
2025 Q1
5 quarters
|
|
3117
Abeona Therapeutics
ABEO
$256M
| $215K | ﹤0.01% |
47,950
+30,030
| +168% | +$165K |
2025 Q2
4 quarters
|
|
3118
Plumas Bancorp
PLBC
$441M
| $215K | ﹤0.01% |
+4,400
| New | +$233K |
2026 Q2
0 quarters
|
|
3119
Acco Brands
ACCO
$432M
| $215K | ﹤0.01% |
71,586
+16,860
| +31% | +$61.9K |
2013 Q2
52 quarters
|
|
3120
Neumora Therapeutics
NMRA
$76.2M
| $215K | ﹤0.01% |
+110,100
| New | +$210K |
2026 Q2
0 quarters
|
|
3121
Tucows
TCX
$133M
| $214K | ﹤0.01% |
12,490
+300
| +2% | +$4.55K |
2024 Q2
8 quarters
|
|
3122
Aclaris Therapeutics
ACRS
$564M
| $214K | ﹤0.01% |
57,000
+41,800
| +275% | +$186K |
2025 Q2
4 quarters
|
|
3123
Shattuck Labs
STTK
$562M
| $213K | ﹤0.01% |
+33,190
| New | +$207K |
2026 Q2
0 quarters
|
|
3124
Nkarta
NKTX
$125M
| $213K | ﹤0.01% |
100,950
+11,080
| +12% | +$31.2K |
2020 Q4
22 quarters
|
|
3125
WEBTOON Entertainment Inc
WBTN
$1.29B
| $210K | ﹤0.01% |
22,900
+7,300
| +47% | +$86.4K |
2025 Q2
4 quarters
|
|
Similar funds
AllianceBernstein's Q2 2026 Portfolio in Review
As of Q2 2026, AllianceBernstein held 3,456 positions worth $302B, down 2.1% from $309B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
AllianceBernstein withdrew a net $10.1B in Q2 2026, closing 139 positions and reducing 1,179 holdings. Its most notable exit was Hologic, an estimated $75.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, AllianceBernstein opened a new position in Honeywell Aerospace worth $183M.
- AllianceBernstein's largest Q2 2026 buy was Honeywell Aerospace: 827,059 shares worth $183M.
- AllianceBernstein added most to Micron Technology in Q2 2026, an estimated $1.21B increase.
- AllianceBernstein's biggest Q2 2026 reduction was Amazon, cutting an estimated $3.74B.
- AllianceBernstein fully exited Hologic in Q2 2026, selling an estimated $75.9M.
- AllianceBernstein's ten largest holdings make up 31% of its $302B portfolio in Q2 2026.
- AllianceBernstein opened 228 new positions and closed 139 in Q2 2026.
- AllianceBernstein's portfolio value fell 2.1% quarter-over-quarter to $302B.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.